Back to search

Article

Tacrolimus rescues endothelial ALK1 loss-of-function signaling and improves HHT vascular pathology

2017-05-13

Abstract excerpt

Hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular disorder arising from endothelial cell (EC) proliferation and hypervascularization, for which no cure exists. Because HHT is caused by loss-of-function mutations in BMP9-ALK1-Smad1/5/8 signaling, interventions aimed at activating this pathway are of therapeutic value. By screening FDA-approved drug libraries, we identified tacrolimus (FK-506) as a p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a8b14e6f-a914-5911-8aca-934bc161a61a
DOI
10.1101/137737
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tacrolimus rescues endothelial ALK1 loss-of-function signaling and improves HHT vascular pathologyDOI 10.1101/137737
Select a neighboring publication to make it the new centre.